MaxCyte, Inc. - Common Stock (NQ:MXCT)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Earnings Scheduled For May 7, 2025
May 07, 2025
A Look at MaxCyte's Upcoming Earnings Report
May 06, 2025
These stocks are moving in today's after hours session
March 11, 2025
Earnings Scheduled For March 11, 2025
March 11, 2025
MarketBeat Week in Review – 01/20 - 01/24
January 25, 2025
MaxCyte: Building the Future of Cell and Gene Therapy Innovation
January 23, 2025
MaxCyte Announces Retirement of Board Member Art Mandell
December 23, 2024
MaxCyte to Participate in Two Upcoming Investor Conferences
October 31, 2024
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
October 10, 2024
Frequently Asked QuestionsIs MaxCyte, Inc. - Common Stock publicly traded?
Yes, MaxCyte, Inc. - Common Stock is publicly traded.
What exchange does MaxCyte, Inc. - Common Stock trade on?
MaxCyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MaxCyte, Inc. - Common Stock?
The ticker symbol for MaxCyte, Inc. - Common Stock is MXCT on the Nasdaq Stock Market
What is the current price of MaxCyte, Inc. - Common Stock?
The current price of MaxCyte, Inc. - Common Stock is 2.250
When was MaxCyte, Inc. - Common Stock last traded?
The last trade of MaxCyte, Inc. - Common Stock was at 07/09/25 04:00 PM ET
What is the market capitalization of MaxCyte, Inc. - Common Stock?
The market capitalization of MaxCyte, Inc. - Common Stock is 237.34M
How many shares of MaxCyte, Inc. - Common Stock are outstanding?
MaxCyte, Inc. - Common Stock has 237M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
